nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—lung cancer	0.46	0.708	CbGbCtD
Tetrabenazine—CYP2D6—Gefitinib—lung cancer	0.0608	0.0934	CbGbCtD
Tetrabenazine—CYP2D6—Vinorelbine—lung cancer	0.0468	0.072	CbGbCtD
Tetrabenazine—CYP2D6—Erlotinib—lung cancer	0.0359	0.0553	CbGbCtD
Tetrabenazine—CYP2D6—Vinblastine—lung cancer	0.0289	0.0444	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—lung cancer	0.0177	0.0273	CbGbCtD
Tetrabenazine—CBR1—Vincristine—Vinorelbine—lung cancer	0.00332	0.46	CbGdCrCtD
Tetrabenazine—CBR1—mammary gland—lung cancer	0.00313	0.194	CbGeAlD
Tetrabenazine—CBR1—Vincristine—Vinblastine—lung cancer	0.00266	0.367	CbGdCrCtD
Tetrabenazine—CBR1—respiratory system—lung cancer	0.00209	0.129	CbGeAlD
Tetrabenazine—CBR1—bronchus—lung cancer	0.00172	0.106	CbGeAlD
Tetrabenazine—CBR1—trachea—lung cancer	0.00154	0.0955	CbGeAlD
Tetrabenazine—CBR1—cardiac atrium—lung cancer	0.00145	0.0897	CbGeAlD
Tetrabenazine—CBR1—Azacitidine—Gemcitabine—lung cancer	0.00125	0.173	CbGdCrCtD
Tetrabenazine—CBR1—bone marrow—lung cancer	0.00122	0.0758	CbGeAlD
Tetrabenazine—CBR1—lung—lung cancer	0.00111	0.0686	CbGeAlD
Tetrabenazine—DRD2—respiratory system—lung cancer	0.000998	0.0618	CbGeAlD
Tetrabenazine—SLC18A2—lung—lung cancer	0.000953	0.059	CbGeAlD
Tetrabenazine—CBR1—lymph node—lung cancer	0.000758	0.0469	CbGeAlD
Tetrabenazine—SLC18A2—lymph node—lung cancer	0.000652	0.0404	CbGeAlD
Tetrabenazine—DRD2—lung—lung cancer	0.00053	0.0328	CbGeAlD
Tetrabenazine—Nausea—Teniposide—lung cancer	0.000431	0.00209	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Paclitaxel—lung cancer	0.00043	0.00209	CcSEcCtD
Tetrabenazine—Hypotension—Vinorelbine—lung cancer	0.00043	0.00209	CcSEcCtD
Tetrabenazine—Urethral disorder—Paclitaxel—lung cancer	0.000427	0.00207	CcSEcCtD
Tetrabenazine—Body temperature increased—Topotecan—lung cancer	0.000425	0.00206	CcSEcCtD
Tetrabenazine—Body temperature increased—Erlotinib—lung cancer	0.000421	0.00204	CcSEcCtD
Tetrabenazine—Leukopenia—Irinotecan—lung cancer	0.000416	0.00202	CcSEcCtD
Tetrabenazine—Eye disorder—Etoposide—lung cancer	0.000415	0.00201	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—lung cancer	0.000415	0.00201	CcSEcCtD
Tetrabenazine—Cardiac disorder—Etoposide—lung cancer	0.000412	0.002	CcSEcCtD
Tetrabenazine—Dyspnoea—Vinorelbine—lung cancer	0.00041	0.00199	CcSEcCtD
Tetrabenazine—Eye disorder—Paclitaxel—lung cancer	0.000407	0.00198	CcSEcCtD
Tetrabenazine—Leukopenia—Gemcitabine—lung cancer	0.000405	0.00197	CcSEcCtD
Tetrabenazine—Cardiac disorder—Paclitaxel—lung cancer	0.000404	0.00196	CcSEcCtD
Tetrabenazine—Angiopathy—Etoposide—lung cancer	0.000403	0.00196	CcSEcCtD
Tetrabenazine—Decreased appetite—Vinorelbine—lung cancer	0.0004	0.00194	CcSEcCtD
Tetrabenazine—Asthenia—Vinblastine—lung cancer	0.000397	0.00193	CcSEcCtD
Tetrabenazine—Fatigue—Vinorelbine—lung cancer	0.000397	0.00193	CcSEcCtD
Tetrabenazine—Tremor—Cisplatin—lung cancer	0.000396	0.00192	CcSEcCtD
Tetrabenazine—Angiopathy—Paclitaxel—lung cancer	0.000395	0.00192	CcSEcCtD
Tetrabenazine—Constipation—Vinorelbine—lung cancer	0.000393	0.00191	CcSEcCtD
Tetrabenazine—Asthenia—Topotecan—lung cancer	0.000386	0.00187	CcSEcCtD
Tetrabenazine—Osteoarthritis—Methotrexate—lung cancer	0.000385	0.00187	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000383	0.00186	CcSEcCtD
Tetrabenazine—Confusional state—Irinotecan—lung cancer	0.000383	0.00186	CcSEcCtD
Tetrabenazine—Asthenia—Erlotinib—lung cancer	0.000382	0.00185	CcSEcCtD
Tetrabenazine—Mental disorder—Paclitaxel—lung cancer	0.000382	0.00185	CcSEcCtD
Tetrabenazine—Feeling abnormal—Vinorelbine—lung cancer	0.000379	0.00184	CcSEcCtD
Tetrabenazine—Diarrhoea—Vinblastine—lung cancer	0.000379	0.00184	CcSEcCtD
Tetrabenazine—Leukopenia—Cisplatin—lung cancer	0.000378	0.00183	CcSEcCtD
Tetrabenazine—Nervous system disorder—Irinotecan—lung cancer	0.000372	0.00181	CcSEcCtD
Tetrabenazine—Tension—Paclitaxel—lung cancer	0.000372	0.00181	CcSEcCtD
Tetrabenazine—Nervousness—Paclitaxel—lung cancer	0.000368	0.00179	CcSEcCtD
Tetrabenazine—Diarrhoea—Topotecan—lung cancer	0.000368	0.00179	CcSEcCtD
Tetrabenazine—Irritability—Methotrexate—lung cancer	0.000367	0.00178	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Irinotecan—lung cancer	0.000367	0.00178	CcSEcCtD
Tetrabenazine—Dizziness—Vinblastine—lung cancer	0.000366	0.00178	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Docetaxel—lung cancer	0.000365	0.00177	CcSEcCtD
Tetrabenazine—Diarrhoea—Erlotinib—lung cancer	0.000364	0.00177	CcSEcCtD
Tetrabenazine—Body temperature increased—Vinorelbine—lung cancer	0.000364	0.00177	CcSEcCtD
Tetrabenazine—Nervous system disorder—Gemcitabine—lung cancer	0.000363	0.00176	CcSEcCtD
Tetrabenazine—Urethral disorder—Docetaxel—lung cancer	0.000362	0.00176	CcSEcCtD
Tetrabenazine—Ataxia—Methotrexate—lung cancer	0.000362	0.00176	CcSEcCtD
Tetrabenazine—Skin disorder—Gemcitabine—lung cancer	0.000359	0.00174	CcSEcCtD
Tetrabenazine—Anxiety—Cisplatin—lung cancer	0.000358	0.00174	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Gemcitabine—lung cancer	0.000357	0.00173	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000357	0.00173	CcSEcCtD
Tetrabenazine—Dizziness—Topotecan—lung cancer	0.000356	0.00173	CcSEcCtD
Tetrabenazine—Tremor—Paclitaxel—lung cancer	0.000355	0.00172	CcSEcCtD
Tetrabenazine—Hypotension—Irinotecan—lung cancer	0.000355	0.00172	CcSEcCtD
Tetrabenazine—Vomiting—Vinblastine—lung cancer	0.000352	0.00171	CcSEcCtD
Tetrabenazine—Dizziness—Erlotinib—lung cancer	0.000352	0.00171	CcSEcCtD
Tetrabenazine—Agitation—Paclitaxel—lung cancer	0.000349	0.00169	CcSEcCtD
Tetrabenazine—Breast disorder—Methotrexate—lung cancer	0.000348	0.00169	CcSEcCtD
Tetrabenazine—Headache—Vinblastine—lung cancer	0.000347	0.00168	CcSEcCtD
Tetrabenazine—Leukopenia—Etoposide—lung cancer	0.000346	0.00168	CcSEcCtD
Tetrabenazine—Hypotension—Gemcitabine—lung cancer	0.000345	0.00168	CcSEcCtD
Tetrabenazine—Eye disorder—Docetaxel—lung cancer	0.000345	0.00167	CcSEcCtD
Tetrabenazine—Insomnia—Irinotecan—lung cancer	0.000343	0.00167	CcSEcCtD
Tetrabenazine—Cardiac disorder—Docetaxel—lung cancer	0.000343	0.00166	CcSEcCtD
Tetrabenazine—Vomiting—Topotecan—lung cancer	0.000342	0.00166	CcSEcCtD
Tetrabenazine—Leukopenia—Paclitaxel—lung cancer	0.000339	0.00165	CcSEcCtD
Tetrabenazine—Vomiting—Erlotinib—lung cancer	0.000338	0.00164	CcSEcCtD
Tetrabenazine—Dyspnoea—Irinotecan—lung cancer	0.000338	0.00164	CcSEcCtD
Tetrabenazine—Nervous system disorder—Cisplatin—lung cancer	0.000338	0.00164	CcSEcCtD
Tetrabenazine—Somnolence—Irinotecan—lung cancer	0.000337	0.00164	CcSEcCtD
Tetrabenazine—Headache—Topotecan—lung cancer	0.000337	0.00164	CcSEcCtD
Tetrabenazine—Angiopathy—Docetaxel—lung cancer	0.000335	0.00163	CcSEcCtD
Tetrabenazine—Skin disorder—Cisplatin—lung cancer	0.000335	0.00162	CcSEcCtD
Tetrabenazine—Insomnia—Gemcitabine—lung cancer	0.000334	0.00162	CcSEcCtD
Tetrabenazine—Headache—Erlotinib—lung cancer	0.000333	0.00162	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—lung cancer	0.000333	0.00162	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Cisplatin—lung cancer	0.000333	0.00162	CcSEcCtD
Tetrabenazine—Asthenia—Vinorelbine—lung cancer	0.00033	0.0016	CcSEcCtD
Tetrabenazine—Decreased appetite—Irinotecan—lung cancer	0.00033	0.0016	CcSEcCtD
Tetrabenazine—Dyspnoea—Gemcitabine—lung cancer	0.00033	0.0016	CcSEcCtD
Tetrabenazine—Nausea—Vinblastine—lung cancer	0.000329	0.0016	CcSEcCtD
Tetrabenazine—Somnolence—Gemcitabine—lung cancer	0.000329	0.00159	CcSEcCtD
Tetrabenazine—Fatigue—Irinotecan—lung cancer	0.000327	0.00159	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000327	0.00159	CcSEcCtD
Tetrabenazine—Constipation—Irinotecan—lung cancer	0.000325	0.00157	CcSEcCtD
Tetrabenazine—Mental disorder—Docetaxel—lung cancer	0.000323	0.00157	CcSEcCtD
Tetrabenazine—Hypotension—Cisplatin—lung cancer	0.000322	0.00156	CcSEcCtD
Tetrabenazine—Anxiety—Paclitaxel—lung cancer	0.000322	0.00156	CcSEcCtD
Tetrabenazine—Decreased appetite—Gemcitabine—lung cancer	0.000321	0.00156	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000321	0.00156	CcSEcCtD
Tetrabenazine—Nausea—Topotecan—lung cancer	0.00032	0.00155	CcSEcCtD
Tetrabenazine—Fatigue—Gemcitabine—lung cancer	0.000319	0.00155	CcSEcCtD
Tetrabenazine—Confusional state—Etoposide—lung cancer	0.000318	0.00154	CcSEcCtD
Tetrabenazine—Constipation—Gemcitabine—lung cancer	0.000316	0.00153	CcSEcCtD
Tetrabenazine—Nausea—Erlotinib—lung cancer	0.000316	0.00153	CcSEcCtD
Tetrabenazine—Dry mouth—Paclitaxel—lung cancer	0.000316	0.00153	CcSEcCtD
Tetrabenazine—Diarrhoea—Vinorelbine—lung cancer	0.000315	0.00153	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—lung cancer	0.000313	0.00152	CcSEcCtD
Tetrabenazine—Feeling abnormal—Irinotecan—lung cancer	0.000313	0.00152	CcSEcCtD
Tetrabenazine—Confusional state—Paclitaxel—lung cancer	0.000312	0.00151	CcSEcCtD
Tetrabenazine—Dysuria—Methotrexate—lung cancer	0.000311	0.00151	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Methotrexate—lung cancer	0.000309	0.0015	CcSEcCtD
Tetrabenazine—Dyspnoea—Cisplatin—lung cancer	0.000307	0.00149	CcSEcCtD
Tetrabenazine—Skin disorder—Etoposide—lung cancer	0.000307	0.00149	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Etoposide—lung cancer	0.000305	0.00148	CcSEcCtD
Tetrabenazine—Feeling abnormal—Gemcitabine—lung cancer	0.000305	0.00148	CcSEcCtD
Tetrabenazine—Dizziness—Vinorelbine—lung cancer	0.000304	0.00148	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—lung cancer	0.000304	0.00148	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000304	0.00148	CcSEcCtD
Tetrabenazine—Nervous system disorder—Paclitaxel—lung cancer	0.000304	0.00147	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—lung cancer	0.000301	0.00146	CcSEcCtD
Tetrabenazine—Skin disorder—Paclitaxel—lung cancer	0.000301	0.00146	CcSEcCtD
Tetrabenazine—Body temperature increased—Irinotecan—lung cancer	0.0003	0.00146	CcSEcCtD
Tetrabenazine—Decreased appetite—Cisplatin—lung cancer	0.0003	0.00145	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Paclitaxel—lung cancer	0.000299	0.00145	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—lung cancer	0.000296	0.00144	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—lung cancer	0.000296	0.00143	CcSEcCtD
Tetrabenazine—Hypotension—Etoposide—lung cancer	0.000295	0.00143	CcSEcCtD
Tetrabenazine—Vomiting—Vinorelbine—lung cancer	0.000293	0.00142	CcSEcCtD
Tetrabenazine—Body temperature increased—Gemcitabine—lung cancer	0.000292	0.00142	CcSEcCtD
Tetrabenazine—Hypotension—Paclitaxel—lung cancer	0.000289	0.0014	CcSEcCtD
Tetrabenazine—Headache—Vinorelbine—lung cancer	0.000288	0.0014	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—lung cancer	0.000288	0.0014	CcSEcCtD
Tetrabenazine—Leukopenia—Docetaxel—lung cancer	0.000288	0.0014	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—lung cancer	0.000284	0.00138	CcSEcCtD
Tetrabenazine—Feeling abnormal—Cisplatin—lung cancer	0.000284	0.00138	CcSEcCtD
Tetrabenazine—Dyspnoea—Etoposide—lung cancer	0.000281	0.00137	CcSEcCtD
Tetrabenazine—Somnolence—Etoposide—lung cancer	0.000281	0.00136	CcSEcCtD
Tetrabenazine—Insomnia—Paclitaxel—lung cancer	0.00028	0.00136	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—lung cancer	0.000277	0.00134	CcSEcCtD
Tetrabenazine—Dyspnoea—Paclitaxel—lung cancer	0.000276	0.00134	CcSEcCtD
Tetrabenazine—Somnolence—Paclitaxel—lung cancer	0.000275	0.00134	CcSEcCtD
Tetrabenazine—Decreased appetite—Etoposide—lung cancer	0.000274	0.00133	CcSEcCtD
Tetrabenazine—Nausea—Vinorelbine—lung cancer	0.000273	0.00133	CcSEcCtD
Tetrabenazine—Body temperature increased—Cisplatin—lung cancer	0.000272	0.00132	CcSEcCtD
Tetrabenazine—Asthenia—Irinotecan—lung cancer	0.000272	0.00132	CcSEcCtD
Tetrabenazine—Fatigue—Etoposide—lung cancer	0.000272	0.00132	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000272	0.00132	CcSEcCtD
Tetrabenazine—Constipation—Etoposide—lung cancer	0.00027	0.00131	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—lung cancer	0.000269	0.00131	CcSEcCtD
Tetrabenazine—Decreased appetite—Paclitaxel—lung cancer	0.000269	0.00131	CcSEcCtD
Tetrabenazine—Dry mouth—Docetaxel—lung cancer	0.000268	0.0013	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000268	0.0013	CcSEcCtD
Tetrabenazine—Fatigue—Paclitaxel—lung cancer	0.000267	0.00129	CcSEcCtD
Tetrabenazine—Asthenia—Gemcitabine—lung cancer	0.000265	0.00129	CcSEcCtD
Tetrabenazine—Constipation—Paclitaxel—lung cancer	0.000265	0.00128	CcSEcCtD
Tetrabenazine—Confusional state—Docetaxel—lung cancer	0.000265	0.00128	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—lung cancer	0.000263	0.00128	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—lung cancer	0.000261	0.00127	CcSEcCtD
Tetrabenazine—Feeling abnormal—Etoposide—lung cancer	0.00026	0.00126	CcSEcCtD
Tetrabenazine—Diarrhoea—Irinotecan—lung cancer	0.00026	0.00126	CcSEcCtD
Tetrabenazine—Nervous system disorder—Docetaxel—lung cancer	0.000257	0.00125	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—lung cancer	0.000257	0.00125	CcSEcCtD
Tetrabenazine—Feeling abnormal—Paclitaxel—lung cancer	0.000255	0.00124	CcSEcCtD
Tetrabenazine—Skin disorder—Docetaxel—lung cancer	0.000255	0.00124	CcSEcCtD
Tetrabenazine—Diarrhoea—Gemcitabine—lung cancer	0.000253	0.00123	CcSEcCtD
Tetrabenazine—Dizziness—Irinotecan—lung cancer	0.000251	0.00122	CcSEcCtD
Tetrabenazine—Body temperature increased—Etoposide—lung cancer	0.00025	0.00121	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—lung cancer	0.000249	0.00121	CcSEcCtD
Tetrabenazine—Asthenia—Cisplatin—lung cancer	0.000247	0.0012	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—lung cancer	0.000247	0.0012	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—lung cancer	0.000246	0.00119	CcSEcCtD
Tetrabenazine—Hypotension—Docetaxel—lung cancer	0.000245	0.00119	CcSEcCtD
Tetrabenazine—Body temperature increased—Paclitaxel—lung cancer	0.000245	0.00119	CcSEcCtD
Tetrabenazine—Angiopathy—Methotrexate—lung cancer	0.000241	0.00117	CcSEcCtD
Tetrabenazine—Vomiting—Irinotecan—lung cancer	0.000241	0.00117	CcSEcCtD
Tetrabenazine—Headache—Irinotecan—lung cancer	0.000238	0.00115	CcSEcCtD
Tetrabenazine—Insomnia—Docetaxel—lung cancer	0.000237	0.00115	CcSEcCtD
Tetrabenazine—Diarrhoea—Cisplatin—lung cancer	0.000236	0.00114	CcSEcCtD
Tetrabenazine—Vomiting—Gemcitabine—lung cancer	0.000235	0.00114	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—lung cancer	0.000235	0.00114	CcSEcCtD
Tetrabenazine—Dyspnoea—Docetaxel—lung cancer	0.000234	0.00113	CcSEcCtD
Tetrabenazine—Somnolence—Docetaxel—lung cancer	0.000233	0.00113	CcSEcCtD
Tetrabenazine—Mental disorder—Methotrexate—lung cancer	0.000233	0.00113	CcSEcCtD
Tetrabenazine—Headache—Gemcitabine—lung cancer	0.000232	0.00112	CcSEcCtD
Tetrabenazine—Decreased appetite—Docetaxel—lung cancer	0.000228	0.00111	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—lung cancer	0.000228	0.0011	CcSEcCtD
Tetrabenazine—Asthenia—Etoposide—lung cancer	0.000226	0.0011	CcSEcCtD
Tetrabenazine—Fatigue—Docetaxel—lung cancer	0.000226	0.0011	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—lung cancer	0.000226	0.0011	CcSEcCtD
Tetrabenazine—Nausea—Irinotecan—lung cancer	0.000225	0.00109	CcSEcCtD
Tetrabenazine—Constipation—Docetaxel—lung cancer	0.000224	0.00109	CcSEcCtD
Tetrabenazine—Asthenia—Paclitaxel—lung cancer	0.000222	0.00108	CcSEcCtD
Tetrabenazine—Nausea—Gemcitabine—lung cancer	0.00022	0.00107	CcSEcCtD
Tetrabenazine—Vomiting—Cisplatin—lung cancer	0.000219	0.00106	CcSEcCtD
Tetrabenazine—Feeling abnormal—Docetaxel—lung cancer	0.000216	0.00105	CcSEcCtD
Tetrabenazine—Diarrhoea—Etoposide—lung cancer	0.000216	0.00105	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—lung cancer	0.000215	0.00105	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—lung cancer	0.000214	0.00104	CcSEcCtD
Tetrabenazine—Diarrhoea—Paclitaxel—lung cancer	0.000212	0.00103	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—lung cancer	0.000209	0.00101	CcSEcCtD
Tetrabenazine—Dizziness—Etoposide—lung cancer	0.000209	0.00101	CcSEcCtD
Tetrabenazine—Body temperature increased—Docetaxel—lung cancer	0.000207	0.00101	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—lung cancer	0.000207	0.00101	CcSEcCtD
Tetrabenazine—Dizziness—Paclitaxel—lung cancer	0.000205	0.000993	CcSEcCtD
Tetrabenazine—Nausea—Cisplatin—lung cancer	0.000205	0.000993	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—lung cancer	0.000202	0.00098	CcSEcCtD
Tetrabenazine—Vomiting—Etoposide—lung cancer	0.000201	0.000974	CcSEcCtD
Tetrabenazine—Headache—Etoposide—lung cancer	0.000198	0.00096	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—lung cancer	0.000197	0.000955	CcSEcCtD
Tetrabenazine—Vomiting—Paclitaxel—lung cancer	0.000197	0.000955	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000196	0.000951	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—lung cancer	0.000195	0.000945	CcSEcCtD
Tetrabenazine—Headache—Paclitaxel—lung cancer	0.000194	0.000941	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—lung cancer	0.000191	0.000925	CcSEcCtD
Tetrabenazine—Asthenia—Docetaxel—lung cancer	0.000188	0.000913	CcSEcCtD
Tetrabenazine—Nausea—Etoposide—lung cancer	0.000188	0.00091	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—lung cancer	0.000185	0.0009	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—lung cancer	0.000184	0.000895	CcSEcCtD
Tetrabenazine—Nausea—Paclitaxel—lung cancer	0.000184	0.000892	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—lung cancer	0.000184	0.000891	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—lung cancer	0.000183	0.000887	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—lung cancer	0.00018	0.000871	CcSEcCtD
Tetrabenazine—Diarrhoea—Docetaxel—lung cancer	0.000179	0.000871	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—lung cancer	0.000177	0.000857	CcSEcCtD
Tetrabenazine—Dizziness—Docetaxel—lung cancer	0.000173	0.000842	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—lung cancer	0.000171	0.00083	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—lung cancer	0.00017	0.000826	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00017	0.000823	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—lung cancer	0.000169	0.000818	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—lung cancer	0.000168	0.000816	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—lung cancer	0.000167	0.000811	CcSEcCtD
Tetrabenazine—Vomiting—Docetaxel—lung cancer	0.000167	0.000809	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—lung cancer	0.000165	0.000801	CcSEcCtD
Tetrabenazine—Decreased appetite—Methotrexate—lung cancer	0.000164	0.000798	CcSEcCtD
Tetrabenazine—Headache—Docetaxel—lung cancer	0.000164	0.000798	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—lung cancer	0.000163	0.000791	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—lung cancer	0.000161	0.000779	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—lung cancer	0.000159	0.000772	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—lung cancer	0.000158	0.000768	CcSEcCtD
Tetrabenazine—Nausea—Docetaxel—lung cancer	0.000156	0.000756	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—lung cancer	0.000156	0.000756	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—lung cancer	0.000153	0.000742	CcSEcCtD
Tetrabenazine—Body temperature increased—Methotrexate—lung cancer	0.000149	0.000725	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—lung cancer	0.000148	0.000719	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—lung cancer	0.000146	0.000708	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—lung cancer	0.000146	0.000706	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—lung cancer	0.000142	0.000691	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—lung cancer	0.000141	0.000685	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—NQO1—lung cancer	0.00014	0.00117	CbGpPWpGaD
Tetrabenazine—Constipation—Doxorubicin—lung cancer	0.00014	0.000679	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—BRAF—lung cancer	0.000139	0.00116	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000137	0.00114	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000136	0.00113	CbGpPWpGaD
Tetrabenazine—Asthenia—Methotrexate—lung cancer	0.000136	0.000658	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—ALB—lung cancer	0.000135	0.00113	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Doxorubicin—lung cancer	0.000135	0.000655	CcSEcCtD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000134	0.00112	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—HPGDS—lung cancer	0.000132	0.0011	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—AVP—lung cancer	0.000131	0.0011	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Doxorubicin—lung cancer	0.000129	0.000628	CcSEcCtD
Tetrabenazine—DRD2—GPCR ligand binding—GRP—lung cancer	0.000129	0.00108	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—OXTR—lung cancer	0.000129	0.00108	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Methotrexate—lung cancer	0.000129	0.000628	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—GSTT1—lung cancer	0.000128	0.00107	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GCLC—lung cancer	0.000127	0.00106	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP2A6—lung cancer	0.000127	0.00106	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—STK11—lung cancer	0.000126	0.00105	CbGpPWpGaD
Tetrabenazine—Dizziness—Methotrexate—lung cancer	0.000125	0.000607	CcSEcCtD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000125	0.00104	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TYMS—lung cancer	0.000125	0.00104	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GNG11—lung cancer	0.000121	0.00101	CbGpPWpGaD
Tetrabenazine—Vomiting—Methotrexate—lung cancer	0.00012	0.000583	CcSEcCtD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000119	0.000988	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000118	0.000988	CbGpPWpGaD
Tetrabenazine—Headache—Methotrexate—lung cancer	0.000118	0.000575	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—lung cancer	0.000117	0.00057	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTP1—lung cancer	0.000117	0.000974	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—MDM2—lung cancer	0.000116	0.000968	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—RAF1—lung cancer	0.000116	0.000964	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CAT—lung cancer	0.000114	0.000948	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—AVP—lung cancer	0.000113	0.000946	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000113	0.000942	CbGpPWpGaD
Tetrabenazine—Nausea—Methotrexate—lung cancer	0.000112	0.000545	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—lung cancer	0.000112	0.000544	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ABCB1—lung cancer	0.000111	0.000922	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.00011	0.000917	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—TYMS—lung cancer	0.000109	0.000905	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000109	0.000905	CbGpPWpGaD
Tetrabenazine—Dizziness—Doxorubicin—lung cancer	0.000108	0.000525	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—CYP2E1—lung cancer	0.000108	0.000898	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTM1—lung cancer	0.000107	0.000895	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	0.000106	0.000886	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GIPR—lung cancer	0.000104	0.000871	CbGpPWpGaD
Tetrabenazine—Vomiting—Doxorubicin—lung cancer	0.000104	0.000505	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—lung cancer	0.000103	0.000498	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CYP1A1—lung cancer	0.000102	0.000848	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PTHLH—lung cancer	0.000101	0.000844	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ERCC2—lung cancer	0.000101	0.000842	CbGpPWpGaD
Tetrabenazine—Nausea—Doxorubicin—lung cancer	9.73e-05	0.000472	CcSEcCtD
Tetrabenazine—DRD2—GPCR ligand binding—ANXA1—lung cancer	9.52e-05	0.000794	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GIPR—lung cancer	9.48e-05	0.000791	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	9.22e-05	0.000769	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—APP—lung cancer	9.02e-05	0.000753	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTP1—lung cancer	8.88e-05	0.00074	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GRM8—lung cancer	8.88e-05	0.00074	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	8.76e-05	0.00073	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APOA1—lung cancer	8.73e-05	0.000728	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—APOA1—lung cancer	8.68e-05	0.000724	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.36e-05	0.000697	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—HRAS—lung cancer	8.31e-05	0.000693	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—lung cancer	8.16e-05	0.00068	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GRM8—lung cancer	8.06e-05	0.000672	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	8.05e-05	0.000671	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CG—lung cancer	7.97e-05	0.000665	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	7.74e-05	0.000645	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—POMC—lung cancer	7.7e-05	0.000642	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	7.63e-05	0.000636	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—POMC—lung cancer	7.59e-05	0.000633	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AXL—lung cancer	7.39e-05	0.000616	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CREBBP—lung cancer	7.39e-05	0.000616	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CREBBP—lung cancer	7.35e-05	0.000613	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—OXTR—lung cancer	7.31e-05	0.00061	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GRP—lung cancer	7.31e-05	0.00061	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—AVP—lung cancer	7.02e-05	0.000585	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CD—lung cancer	7.01e-05	0.000584	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ALB—lung cancer	6.92e-05	0.000577	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ALB—lung cancer	6.88e-05	0.000573	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GNG11—lung cancer	6.84e-05	0.000571	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AZIN2—lung cancer	6.8e-05	0.000567	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—COL4A3BP—lung cancer	6.8e-05	0.000567	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GRP—lung cancer	6.64e-05	0.000554	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—OXTR—lung cancer	6.64e-05	0.000554	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HRAS—lung cancer	6.37e-05	0.000531	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—JUN—lung cancer	6.28e-05	0.000523	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—RAF1—lung cancer	6.22e-05	0.000519	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GNG11—lung cancer	6.22e-05	0.000518	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADCY1—lung cancer	6.15e-05	0.000513	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	6.12e-05	0.000511	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CB—lung cancer	6.11e-05	0.000509	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—lung cancer	6.07e-05	0.000506	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS2—lung cancer	6.05e-05	0.000505	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCL8—lung cancer	5.96e-05	0.000497	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EP300—lung cancer	5.79e-05	0.000483	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ATP5H—lung cancer	5.79e-05	0.000482	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—POMC—lung cancer	5.77e-05	0.000481	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—COL4A2—lung cancer	5.75e-05	0.000479	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTHLH—lung cancer	5.72e-05	0.000477	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GIPR—lung cancer	5.6e-05	0.000467	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADCY1—lung cancer	5.59e-05	0.000466	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PPP2R1B—lung cancer	5.45e-05	0.000454	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ANXA1—lung cancer	5.38e-05	0.000449	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—lung cancer	5.28e-05	0.00044	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SDC4—lung cancer	5.23e-05	0.000436	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTHLH—lung cancer	5.2e-05	0.000433	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PLBD1—lung cancer	5.16e-05	0.00043	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DUSP3—lung cancer	5.12e-05	0.000427	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—APP—lung cancer	5.1e-05	0.000425	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—EP300—lung cancer	5.03e-05	0.00042	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RHEB—lung cancer	5.02e-05	0.000419	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ANXA1—lung cancer	4.89e-05	0.000407	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRM8—lung cancer	4.76e-05	0.000397	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	4.74e-05	0.000395	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD17B10—lung cancer	4.72e-05	0.000393	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—POMC—lung cancer	4.66e-05	0.000389	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—APP—lung cancer	4.63e-05	0.000386	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SKI—lung cancer	4.61e-05	0.000385	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CKB—lung cancer	4.38e-05	0.000366	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—lung cancer	4.14e-05	0.000346	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CNDP2—lung cancer	4.12e-05	0.000344	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM2—lung cancer	4.12e-05	0.000344	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTMR3—lung cancer	4.01e-05	0.000334	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PXN—lung cancer	4.01e-05	0.000334	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AVP—lung cancer	3.97e-05	0.000331	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRP—lung cancer	3.92e-05	0.000327	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1C1—lung cancer	3.92e-05	0.000327	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—OXTR—lung cancer	3.92e-05	0.000327	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PGAM1—lung cancer	3.91e-05	0.000326	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—lung cancer	3.79e-05	0.000316	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2A7—lung cancer	3.73e-05	0.000311	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—lung cancer	3.72e-05	0.00031	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNG11—lung cancer	3.67e-05	0.000306	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SDC4—lung cancer	3.65e-05	0.000304	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—lung cancer	3.61e-05	0.000301	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AVP—lung cancer	3.6e-05	0.0003	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFC—lung cancer	3.5e-05	0.000292	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA3—lung cancer	3.32e-05	0.000277	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RRM1—lung cancer	3.32e-05	0.000277	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADCY1—lung cancer	3.3e-05	0.000275	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PPP2R1B—lung cancer	3.22e-05	0.000268	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SMARCA4—lung cancer	3.22e-05	0.000268	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—B4GALT5—lung cancer	3.12e-05	0.000261	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HSPB1—lung cancer	3.1e-05	0.000259	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTHLH—lung cancer	3.07e-05	0.000256	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—lung cancer	3.04e-05	0.000254	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA4—lung cancer	3.04e-05	0.000253	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA2—lung cancer	2.96e-05	0.000247	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ANXA1—lung cancer	2.89e-05	0.000241	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA1—lung cancer	2.86e-05	0.000238	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCC3—lung cancer	2.83e-05	0.000236	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FLT1—lung cancer	2.79e-05	0.000233	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CG—lung cancer	2.77e-05	0.000231	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C1—lung cancer	2.74e-05	0.000228	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APP—lung cancer	2.74e-05	0.000228	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH3—lung cancer	2.74e-05	0.000228	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF9—lung cancer	2.71e-05	0.000226	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UGT1A1—lung cancer	2.66e-05	0.000222	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—POMC—lung cancer	2.64e-05	0.00022	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUNB—lung cancer	2.59e-05	0.000216	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GNG11—lung cancer	2.56e-05	0.000214	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CG—lung cancer	2.51e-05	0.00021	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDOA—lung cancer	2.44e-05	0.000203	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CD—lung cancer	2.43e-05	0.000203	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—POMC—lung cancer	2.39e-05	0.0002	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA3—lung cancer	2.37e-05	0.000197	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STK11—lung cancer	2.35e-05	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6R—lung cancer	2.33e-05	0.000195	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ADCY1—lung cancer	2.3e-05	0.000192	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCG2—lung cancer	2.3e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FOXO3—lung cancer	2.27e-05	0.000189	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGDS—lung cancer	2.26e-05	0.000188	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ENO2—lung cancer	2.26e-05	0.000188	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.24e-05	0.000187	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAP2K1—lung cancer	2.22e-05	0.000186	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CD—lung cancer	2.21e-05	0.000184	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—lung cancer	2.19e-05	0.000183	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCLC—lung cancer	2.17e-05	0.000181	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2A6—lung cancer	2.17e-05	0.000181	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AVP—lung cancer	2.13e-05	0.000177	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CB—lung cancer	2.12e-05	0.000177	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ENO1—lung cancer	2.05e-05	0.000171	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—lung cancer	2.05e-05	0.000171	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—lung cancer	2.04e-05	0.00017	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HES1—lung cancer	2.01e-05	0.000168	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RAF1—lung cancer	1.97e-05	0.000165	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—lung cancer	1.95e-05	0.000162	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CB—lung cancer	1.93e-05	0.000161	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—lung cancer	1.85e-05	0.000154	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.84e-05	0.000154	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB3—lung cancer	1.84e-05	0.000153	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NQO1—lung cancer	1.82e-05	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—lung cancer	1.77e-05	0.000148	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—lung cancer	1.76e-05	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR1—lung cancer	1.71e-05	0.000143	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIF1A—lung cancer	1.69e-05	0.000141	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STK11—lung cancer	1.64e-05	0.000137	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APOA1—lung cancer	1.63e-05	0.000136	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KDR—lung cancer	1.61e-05	0.000134	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—lung cancer	1.52e-05	0.000127	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APC—lung cancer	1.49e-05	0.000124	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KIT—lung cancer	1.49e-05	0.000124	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CG—lung cancer	1.49e-05	0.000124	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—NRAS—lung cancer	1.49e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CAT—lung cancer	1.48e-05	0.000123	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGF—lung cancer	1.47e-05	0.000122	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCB1—lung cancer	1.44e-05	0.00012	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAPK3—lung cancer	1.42e-05	0.000119	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—POMC—lung cancer	1.41e-05	0.000118	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMS—lung cancer	1.41e-05	0.000118	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BRAF—lung cancer	1.4e-05	0.000116	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—lung cancer	1.4e-05	0.000116	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6R—lung cancer	1.38e-05	0.000115	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CREBBP—lung cancer	1.38e-05	0.000115	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—lung cancer	1.35e-05	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.32e-05	0.00011	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAP2K1—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ERCC2—lung cancer	1.31e-05	0.000109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CD—lung cancer	1.31e-05	0.000109	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	1.29e-05	0.000108	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—lung cancer	1.28e-05	0.000107	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	1.17e-05	9.79e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MDM2—lung cancer	1.17e-05	9.75e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RAF1—lung cancer	1.17e-05	9.72e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB2—lung cancer	1.15e-05	9.62e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CB—lung cancer	1.14e-05	9.49e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTOR—lung cancer	1.14e-05	9.49e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APOA1—lung cancer	1.13e-05	9.46e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—lung cancer	1.09e-05	9.12e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—lung cancer	1.09e-05	9.06e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.06e-05	8.81e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—lung cancer	1.05e-05	8.73e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—lung cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—lung cancer	1.04e-05	8.67e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.04e-05	8.64e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—lung cancer	1.02e-05	8.5e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUN—lung cancer	1.02e-05	8.48e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—lung cancer	9.89e-06	8.25e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—POMC—lung cancer	9.86e-06	8.22e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1A—lung cancer	9.86e-06	8.22e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—lung cancer	9.83e-06	8.2e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CREBBP—lung cancer	9.61e-06	8.01e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—lung cancer	9.59e-06	8e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EP300—lung cancer	9.38e-06	7.82e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—lung cancer	9.12e-06	7.61e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CD—lung cancer	9.11e-06	7.6e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALB—lung cancer	8.99e-06	7.5e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—lung cancer	8.88e-06	7.41e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT3—lung cancer	8.8e-06	7.33e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRAS—lung cancer	8.77e-06	7.32e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK3—lung cancer	8.4e-06	7.01e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—lung cancer	8.17e-06	6.82e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—lung cancer	7.99e-06	6.67e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CB—lung cancer	7.94e-06	6.62e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—lung cancer	7.87e-06	6.56e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—lung cancer	7.55e-06	6.3e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	6.94e-06	5.79e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—lung cancer	6.86e-06	5.72e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—lung cancer	6.71e-06	5.6e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—EP300—lung cancer	6.54e-06	5.46e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—lung cancer	6.42e-06	5.35e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—lung cancer	6.14e-06	5.12e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—lung cancer	5.67e-06	4.73e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—lung cancer	4.84e-06	4.04e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—lung cancer	3.95e-06	3.3e-05	CbGpPWpGaD
